By James Muonwa
THE University of Zimbabwe (UZ), which has been leading research and innovation on Zumbani (Lippia Javanica), is on the brink of putting three products made from the locally available medicinal herb on shop shelves.
Obert Jiri, a professor at the UZ research and innovation directorate told NewZimbabwe.com, Zumbani products that have proven medicinal properties to manage Covid-19 and other ailments, were in the process of being registered with the medicines regulator, Medicines Control Authority of Zimbabwe (MCAZ).
“Research has produced some things that are helpful, such as Zumbani ointment, capsules, and tea which we are producing at the university,” he said.
Interview with Zimbabwe’s Dr. Jackie Stone: COVID-19 Infection & Death Rates Plummet After Medicines Control Authority of Zimbabwe (MCAZ) Greenlight for Ivermectin Use
Posted on
TrialSite’s world survey of the various attempts to stave off and overcome COVID-19 brings the reader back to Zimbabwe, the location of an incredible, underreported scenario urging more attention. TrialSite first covered Zimbabwe when that nation’s medicines regulatory body decided to allow the use of ivermectin for research, and importantly, for research as a care option during the COVID-19 pandemic. This country experienced a relatively small wave of infections in August 2020 and then a far deadlier, steeper rise in December 2020 into the New Year. With some high profile members of the society (politicians, military leaders, etc.) infected, followed by some deaths, by January 27
Search jobs 04-May-2021 Global Cold, Cough, and Sore Throat Remedies Market Size [2021] Emerging Trends, Growing At A CAGR of 3.6%, Finds Coherent Market Insights
SEATTLE, April 14, 2021, (PHARMIWEB) –
Overview
Cold, cough, and sore throat medications only help to alleviate symptoms. The time it takes for a cold to develop is usually between 24 and 72 hours. Nasal inflammation, mild fever, sneezing, sore throat, lack of appetite, fatigue, irritability, and other symptoms are all manifestations of a cold.
In terms of size, the global cold, cough, and sore throat remedies market is expected to hit US$ 36,325.0 million in 2019 and US$ 46,869.6 million by 2027.
To learn more about this report, request a sample copy
By Staff Reporter
MDC Alliance says there is no transparency and accountability in the choices of Covid-19 vaccines to both the health sector and the entire population.
In a statement weekend, MDC Alliance secretary for Health and Child Care, North American province Simbiso Ranga said medical professionals in Zimbabwe should lead the charge for success against Covid-19.
“How the vaccination program is managed will determine whether Zimbabwe succeeds or fails. The medical professionals should lead the charge for success.
“As much as the government determines policy regarding issues like Covid-19 regulations and vaccine choices, these policies should be based on the best advice of medical professionals and institutions.
By Robert Tapfumaneyi
CABINET Tuesday approved the pharmaceutical manufacturing strategy which is expected to, among other things, test the efficacy of the much-talked-about Zumbani traditional herb for treating Covid-19.
This was announced by government ministers during the post-Cabinet press briefing.
“What we have done is to embrace what we call the triple model. What it means is a more concerted effort towards research and innovation,” Industry Minister Sekai Nzenza said.
“They will be a collaborative approach with the line ministries, stakeholders, as well as the private sector, and our main aim, is to achieve this through competitiveness, availability, and competitiveness of locally manufactured medicines.